Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene

American Journal of Cardiology

Volumn 94, Issue 5, 2004, Pages 564-569

  Trevelyan, Jasper ^a,b,d   Brull, David J ^c   Needham, Edward W A ^b   Montgomery, Hugh E ^c   Morris, Alan ^b   Mattu, Raj K ^a,b  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOSINE; ENALAPRIL; GUANINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LOSARTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE RELEASE; DRUG EFFECT; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE;

AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE AGENTS; CORONARY ARTERY BYPASS; CYTOKINES; ENALAPRIL; GENOTYPE; HUMANS; INTERLEUKIN-6; LOSARTAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 4444268576     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.05.017     Document Type: Article

References (19)

1. M. Martin, K. Surral, F. McKenna, J. Dixon, H. Bird, V. Wright Captopril a new treatment for rheumatoid arthritis? Lancet 1 1984 1325 1328
2. The Heart Outcomes Prevention Evaluation Study Investigators Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients N Engl J Med 342 2000 145 153
3. B. Dahlof, R.B. Devereux, S.E. Kjeldsen, S. Julius, G. Beevers, U. Faire, F. Fyhrquist, H. Ibsen, K. Kristiansson, O Lederballe-Pedersen for the Life Study Group Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) a randomised trial against atenolol Lancet 359 2002 995 991003
4. R. Hall, M. Smith, G. Rocker The systemic inflammatory response to cardiopulmonary bypass pathophysiological, therapeutic and pharmacological considerations Anesth Analg 85 1997 766 782
5. D. Fishman, G. Faulds, R. Jeffery, V. Mohamed-Ali, J.S. Yudkin, S.E. Humphries, P. Woo The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369 1376
6. C.F. Terry, V. Loukaci, F.R. Green Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation J Biol Chem 275 2000 18138 18144
7. D.J. Brull, H.E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G.D.O. Lowe, S.E. Humphries Interleukin-6 gene -174G→C and -572G→C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery Arterioscler Thromb Vasc Biol 21 2001 1458 1463
8. F. Burzotta, L. Iacoviello, A. Di Castelnuovo, F. Glieca, N. Luciani, R. Zamparelli, R. Schiavello, M.B. Donati, A. Maseri, G.F. Possati, F. Andreotti Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization Am J Cardiol 88 2001 1125 1128
9. J.N.S. Matthews, D.G. Altman, M.J. Campbell, P. Royston Analysis of serial measurements in medical research BMJ 300 1990 230 235
10. J.A. Richter, H. Meisner, P. Tassani, A. Baranky, W. Dietrich, S.L. Braun Drew-Anderson technique attentuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting Ann Thorac Surg 69 1999 77 83
11. A. Hahn, U. Jonas, F. Buhler, T. Redink Activation of human peripheral monocytes by angiotensin II FEBS Lett 347 1994 178 180
12. D. Gurantz, R.T. Cowling, F.J. Villarreal, B.H. Greenberg Tumor necrosis factor-{alpha} upregulates angiotensin II type 1 receptors on cardiac fibroblasts Circ Res 85 1999 272 279
13. C.S. Constantinescu, D.B. Goodman, E.S. Ventura Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells Immunol Lett 62 1998 25 31
14. A. Peeters, M. Netea, B. Kullberg, T. Thien, J. van der Meer The effect of renin-angiotesin system inhibitors on pro- and anti-inflammatory cytokine production Immunology 94 1998 376 379
15. R. Schindler, C.A. Dinarello, K.M. Koch Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells Cytokine 7 1995 526 533
16. M. Rathaus, E. Podjarny, A. Pomeranz, J. Bernheim NaCl modulates captopril effects on glomerular prostaglandin synthesis and glomerular filtration Am J Physiol 258 1990 F382 F387
17. T. Eisenhut, B. Shinha, E. Wolfers, J. Semmler, W. Siess, S. Endres Prostacyclin analogs suppress the synthesis of tumour necrosis factor-α in LPS-stimulated human peripheral blood mononuclear cells Immunopharmacology 26 1993 259 264
18. C. Tannenbaum, T. Hamilton Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP J Immunol 142 1989 1247 1280
19. W. Linz, B.A. Scholkens Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors J Cardiovasc Pharmacol 20 suppl 9 1992 S83 90